Bright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conference
VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG)...
Staff
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
CANTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on...
Viemed Healthcare Announces Share Repurchase Program
LAFAYETTE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a home...
Neuronetics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic...
Plantable Health’s Trial at Memorial Sloan Kettering Aims to Reduce Risk Factors Associated With Breast Cancer
New York, New York--(Newsfile Corp. - March 8, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today...
Halberd Expands Its Technical Expertise With the Addition of Microbiology Professor
Jackson Center, Pennsylvania--(Newsfile Corp. - March 8, 2022) - Halberd Corporation (OTC PINK: HALB) is pleased to announce Youngstown State...
CBD of Denver Appoints Finance Veteran as New CEO
Company to host an investor update call via Zoom this Thursday at 11:00 a.m. ETDenver, Colorado--(Newsfile Corp. - March 8,...
Psyched Wellness GRAS Dossier Approved by Panel of Experts, Providing Green Light to Market Products in the United States
Toronto, Ontario--(Newsfile Corp. - March 8, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE:5U9) (the "Company" or "Psyched")...
DNAnexus Secures $200 Million Funding Led by Blackstone Growth to Advance its Biomedical Data-Driven Technology Platform for Precision Medicine
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--#Bioinformatics--DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today...
PAVmed to Hold a Business Update Conference Call on March 29, 2022
Company conference call and webcast at 4:30 PM EDT NEW YORK--(BUSINESS WIRE)--$PAVM #Healthcare--PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a highly differentiated,...
Novo Integrated Sciences’ IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #Benzinga--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health...
Titan Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today...
VUZE Medical Announces New Worldwide Patents
Real-time Image Processing Enables Software-Only Guidance and Verification in Minimally Invasive Spine Surgery RA’ANANA, Israel--(BUSINESS WIRE)--#medtech--VUZE Medical, a privately held...
Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System
Axonics sets recharge-free neuromodulation benchmark with FDA labeling for 15+ years of functional life at typical stimulation parameters and 20+...
CloudWave Introduces New OpSus Vault Backup as a Service Offering for Healthcare
Secure Enterprise Cloud Service Protects Valuable Data Backups from Ransomware and Other Threats with an Offline and Immutable Storage Location...
New Research from Cloudmed and Becker’s Healthcare Reveals Significant Untapped Automation Opportunity Remains in Healthcare Revenue Cycle Management
Latest survey shows nearly half of healthcare providers have not yet adopted RPA, with all respondents expecting labor efficiency and...
Lumeon Announces Appointment of John Glaser to Board of Directors as Non-Executive Director
BOSTON--(BUSINESS WIRE)--Lumeon, a leader in care journey orchestration, today announced the appointment of John Glaser to the Lumeon Board of...
BioPorto announces intention to initiate a rights issue with expected gross proceeds of up to approximately DKK 100.4M, updates on status of The NGAL Test clinical trials, and announces its financial estimate for 2021 and guidance for 2022,
March 7, 2022Announcement no. 1 BioPorto announces intention to initiate a rights issue with expected gross proceeds of up to...
Surgalign Announces Appointment of David Lyle as Chief Financial Officer
DEERFIELD, Ill., March 07, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA) (“Surgalign”), a global medical technology company focused...
AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...